000 01392 a2200361 4500
005 20250515060910.0
264 0 _c20070427
008 200704s 0 0 eng d
022 _a1431-6730
024 7 _a10.1515/BC.2007.037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeidauer, Enrico
245 0 0 _aEffects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S.
_h[electronic resource]
260 _bBiological chemistry
_cMar 2007
300 _a331-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntirheumatic Agents
_xpharmacology
650 0 4 _aArthritis, Rheumatoid
_xenzymology
650 0 4 _aCathepsin K
650 0 4 _aCathepsins
_xmetabolism
650 0 4 _aChloroquine
_xpharmacology
650 0 4 _aCysteine Proteinase Inhibitors
_xpharmacology
650 0 4 _aFibroblasts
_xdrug effects
650 0 4 _aGold Sodium Thiomalate
_xpharmacology
650 0 4 _aSynovitis
_xpathology
700 1 _aYasuda, Yoshiyuki
700 1 _aBiswal, Bichitra K
700 1 _aCherny, Maia
700 1 _aJames, Michael N G
700 1 _aBrömme, Dieter
773 0 _tBiological chemistry
_gvol. 388
_gno. 3
_gp. 331-6
856 4 0 _uhttps://doi.org/10.1515/BC.2007.037
_zAvailable from publisher's website
999 _c16895655
_d16895655